Veradigm Price to Book Ratio 2012-2022 | MDRX
Historical price to book ratio values for Veradigm (MDRX) over the last 10 years. The current price to book ratio for Veradigm as of September 18, 2026 is 0.64.
| Veradigm Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-18 | 4.70 | 0.49 | |
| 2022-12-31 | 17.64 | $9.59 | 1.84 |
| 2022-09-30 | 15.23 | $10.77 | 1.41 |
| 2022-06-30 | 14.83 | $10.80 | 1.37 |
| 2022-03-31 | 22.52 | $11.79 | 1.91 |
| 2021-12-31 | 18.45 | $11.72 | 1.57 |
| 2021-09-30 | 13.37 | $11.57 | 1.16 |
| 2021-06-30 | 18.51 | $11.15 | 1.66 |
| 2021-03-31 | 15.02 | $11.94 | 1.26 |
| 2020-12-31 | 14.44 | $11.91 | 1.21 |
| 2020-09-30 | 8.14 | $7.65 | 1.06 |
| 2020-06-30 | 6.77 | $7.63 | 0.89 |
| 2020-03-31 | 7.04 | $7.67 | 0.92 |
| 2019-12-31 | 9.82 | $7.91 | 1.24 |
| 2019-09-30 | 10.98 | $7.85 | 1.40 |
| 2019-06-30 | 11.63 | $7.90 | 1.47 |
| 2019-03-31 | 9.54 | $8.76 | 1.09 |
| 2018-12-31 | 9.64 | $9.23 | 1.04 |
| 2018-09-30 | 14.25 | $6.39 | 2.23 |
| 2018-06-30 | 12.00 | $6.54 | 1.83 |
| 2018-03-31 | 12.35 | $6.24 | 1.98 |
| 2017-12-31 | 14.55 | $6.42 | 2.27 |
| 2017-09-30 | 14.23 | $6.35 | 2.24 |
| 2017-06-30 | 12.76 | $6.45 | 1.98 |
| 2017-03-31 | 12.68 | $6.55 | 1.94 |
| 2016-12-31 | 10.21 | $7.05 | 1.45 |
| 2016-09-30 | 13.17 | $7.40 | 1.78 |
| 2016-06-30 | 12.70 | $7.24 | 1.75 |
| 2016-03-31 | 13.21 | $7.43 | 1.78 |
| 2015-12-31 | 15.38 | $7.50 | 2.05 |
| 2015-09-30 | 12.40 | $7.38 | 1.68 |
| 2015-06-30 | 13.68 | $7.37 | 1.86 |
| 2015-03-31 | 11.96 | $7.07 | 1.69 |
| 2014-12-31 | 12.77 | $7.12 | 1.79 |
| 2014-09-30 | 13.42 | $7.12 | 1.89 |
| 2014-06-30 | 16.05 | $7.21 | 2.23 |
| 2014-03-31 | 18.03 | $7.29 | 2.47 |
| 2013-12-31 | 15.46 | $7.37 | 2.10 |
| 2013-09-30 | 14.87 | $7.46 | 1.99 |
| 2013-06-30 | 12.94 | $7.68 | 1.68 |
| 2013-03-31 | 13.59 | $7.53 | 1.80 |
| 2012-12-31 | 9.42 | $7.45 | 1.26 |
| 2012-09-30 | 12.42 | $7.58 | 1.64 |
| 2012-06-30 | 10.93 | $7.48 | 1.46 |
| 2012-03-31 | 16.60 | $7.81 | 2.13 |
| 2011-12-31 | 18.94 | $7.76 | 2.44 |
| 2011-09-30 | 18.02 | $7.62 | 2.36 |
| 2011-06-30 | 19.42 | $7.49 | 2.59 |
| 2011-03-31 | 20.99 | $7.51 | 2.80 |
| 2010-12-31 | 19.27 | $7.35 | 2.62 |
| 2010-09-30 | 18.47 | $7.35 | 2.51 |
| 2010-06-30 | 16.10 | 0.00 | |
| 2010-05-31 | 18.81 | $5.51 | 3.41 |
| 2010-03-31 | 19.58 | 0.00 | |
| 2010-02-28 | 17.89 | $5.39 | 3.32 |
| 2009-12-31 | 20.23 | $5.27 | 3.84 |
| 2009-11-30 | 19.20 | $5.25 | 3.66 |
| 2009-09-30 | 20.27 | 0.00 | |
| 2009-08-31 | 14.85 | $5.09 | 2.92 |
| 2009-05-31 | 12.91 | $4.92 | 2.62 |
| 2009-02-28 | 8.70 | $4.95 | 1.76 |
| 2008-11-30 | 7.70 | $4.93 | 1.56 |
| 2008-09-30 | 6.61 | $6.15 | 1.07 |
| 2008-08-31 | 7.62 | 0.00 | |
| 2008-06-30 | 6.59 | $6.06 | 1.09 |
| 2008-05-31 | 6.60 | $1.33 | 4.95 |
| 2008-03-31 | 5.48 | $6.01 | 0.91 |
| 2008-02-29 | 5.67 | 0.00 | |
| 2007-12-31 | 10.32 | $5.98 | 1.72 |
| 2007-11-30 | 9.40 | 0.00 | |
| 2007-09-30 | 14.36 | $5.85 | 2.45 |
| 2007-06-30 | 13.54 | $5.99 | 2.26 |
| 2007-05-31 | 13.05 | 0.00 | |
| 2007-03-31 | 14.25 | $5.89 | 2.42 |
| 2006-12-31 | 14.34 | $5.82 | 2.47 |
| 2006-09-30 | 11.95 | $5.71 | 2.09 |
| 2006-06-30 | 9.33 | $5.66 | 1.65 |
| 2006-03-31 | 9.73 | $5.60 | 1.74 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.587B | $0.594B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $42.703B | 42.61 |
| Tempus AI (TEM) | United States | $14.500B | 0.00 |
| 10x Genomics (TXG) | United States | $10.029B | 0.00 |
| Hinge Health (HNGE) | United States | $7.643B | 73.43 |
| Hims & Hers Health (HIMS) | United States | $6.507B | 0.00 |
| Doximity (DOCS) | United States | $4.736B | 29.20 |
| Heartflow (HTFL) | United States | $4.310B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.684B | 242.93 |
| Privia Health (PRVA) | United States | $2.566B | 95.67 |
| Clover Health Investments (CLOV) | United States | $2.411B | 0.00 |
| Schrodinger (SDGR) | United States | $2.232B | 0.00 |
| Butterfly Network (BFLY) | United States | $2.120B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.103B | 32.04 |
| Omnicell (OMCL) | United States | $1.484B | 21.18 |
| Azenta (AZTA) | United States | $1.473B | 80.07 |
| Enovis (ENOV) | United States | $1.027B | 5.31 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.716B | 0.00 |
| Phreesia (PHR) | United States | $0.638B | 34.27 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Claritev (CTEV) | United States | $0.538B | 0.00 |
| Carlsmed (CARL) | United States | $0.420B | 0.00 |
| Evolent Health (EVH) | United States | $0.415B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.394B | 0.00 |
| CapsoVision (CV) | United States | $0.317B | 0.00 |
| Standard BioTools (LAB) | United States | $0.287B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.135B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.094B | 6.94 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Outset Medical (OM) | United States | $0.058B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.058B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.047B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.027B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| HeartSciences (HSCS) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |